THERAPEUTIC USE OF A TLR AGONIST AND COMBINATION THERAPY
摘要
<p num="1">The present invention is directed generally to formulations of a TLR agonist preferably a TLR8 agonist, and its use in the treatment of various diseases, including combination therapies for treating cancer.
申请公布号
CA2812790(A1)
申请公布日期
2012.04.05
申请号
CA20112812790
申请日期
2011.10.03
申请人
VENTIRX PHARMACEUTICALS, INC.;THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
发明人
HERSHBERG, ROBERT;COUKOS, GEORGE;DIETSCH, GREGORY;FACCIABENE, ANDREA;MANJARREZ, KRISTI;RANDALL, TRESSA D.
